HeXun Biosciences Co (ROCO:6986) Research & Development: NT$55.4 Mil (TTM As of Dec. 2025)


ROCO:6986 HeXun Biosciences Co Ltd ROCO:6986
23 GF Score
Price NT$47.00
! 1 Warning Sign
View Full Analysis

What is HeXun Biosciences Co Research & Development?

HeXun Biosciences Co ROCO:6986 23 Research & Development is NT$55.4 Mil as of Dec. 2025. GuruFocus rates ROCO:6986 with a GF Score™ of 23/100. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. HeXun Biosciences Co's Research & Development for the three months ended in Dec. 2025 was NT$30.3 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was NT$55.4 Mil.

HeXun Biosciences Co  (ROCO:6986) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

HeXun Biosciences Co Research & Development Related Terms

HeXun Biosciences Co Research & Development Historical Data

* Premium members only.

The historical data trend for HeXun Biosciences Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HeXun Biosciences Co Research & Development Chart

HeXun Biosciences Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 44.71 39.36 53.22 65.37 99.18

HeXun Biosciences Co Quarterly Data
Dec20 Dec21 Dec22 Jun23 Dec23 Jun24 Sep24 Dec24 Jun25 Sep25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 16.62 15.90 0.00 25.12 30.32
ROCO:6986
23GF Score
HeXun Biosciences Co Ltd ROCO:6986
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HeXun Biosciences Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$55.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of NT$55.4 Mil mean?
HeXun Biosciences Co (ROCO:6986) has a Research & Development of NT$55.4 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on HeXun Biosciences Co and its competitors.
Is HeXun Biosciences Co's Research & Development too high?
HeXun Biosciences Co's current Research & Development is NT$55.4 Mil. Overall, HeXun Biosciences Co has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does HeXun Biosciences Co's Research & Development compare to VRTX and REGN?
HeXun Biosciences Co's Research & Development of NT$55.4 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on HeXun Biosciences Co and its competitors. HeXun Biosciences Co's current Research & Development is NT$55.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HeXun Biosciences Co stock overvalued right now?
HeXun Biosciences Co (ROCO:6986) has a current Research & Development of NT$55.4 Mil. The current Research & Development is NT$55.4 Mil. HeXun Biosciences Co's overall GF Score™ is 23/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For HeXun Biosciences Co (ROCO:6986), the current Research & Development is NT$55.4 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HeXun Biosciences Co Business Description

Address Chunri Road, 6 F., No. 1490, Taoyuan District, Taoyuan, TWN
HeXun Biosciences Co Ltd is engaged in the research and development of cell drugs and cell derivatives. It conducts research and development jointly with medical research institutions to use stem cells to treat cardiovascular, immune-inflammatory, and neurodegenerative diseases to develop innovative cell drugs and treatment methods. The company's main business items are new drug research and development, biotechnology services, and research and development services, such as: commissioned research and development and production services for cell medicine, agency testing and development services, and biomedical consulting services, etc.
23GF Score

Get the complete analysis for ROCO:6986

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$47.00
Price